CD8A and cancer: Thus, particularly in the case of cancers where tumor antigen density and/or T cell infiltration is low, local sensing and presentation of tumor neoantigens via dendritic cells to T cells is a critical rate-limiting step in driving host-mediated CD8+ immunity to neoplastic cells4.